{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:13:36Z","timestamp":1790792016051,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006832","name":"Center for HIV\/AIDS Vaccine Immunology and Immunogen Discovery","doi-asserted-by":"publisher","award":["UM1AI100663"],"award-info":[{"award-number":["UM1AI100663"]}],"id":[{"id":"10.13039\/100006832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.coviro.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T03:45:56Z","timestamp":1425613556000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design"],"prefix":"10.1016","volume":"11","author":[{"given":"Max","family":"Crispin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie J","family":"Doores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.02.002_bib0370","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coviro.2015.02.002_bib0375","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","article-title":"Assembly of asparagine-linked oligosaccharides","volume":"54","author":"Kornfeld","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.coviro.2015.02.002_bib0380","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nature05818","article-title":"Exploiting the defensive sugars of HIV-1 for drug and vaccine design","volume":"446","author":"Scanlan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409239709085144","article-title":"Glycosylation: heterogeneity and the 3D structure of proteins","volume":"32","author":"Rudd","year":"1997","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0390","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/pr401162k","article-title":"Structural plasticity of the semliki forest virus glycome upon interspecies transmission","volume":"13","author":"Crispin","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.coviro.2015.02.002_bib0395","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/infdis\/jir173","article-title":"Lectin switching during dengue virus infection","volume":"203","author":"Dejnirattisai","year":"2011","journal-title":"J Infect Dis"},{"issue":"Pt 9","key":"10.1016\/j.coviro.2015.02.002_bib0400","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1099\/vir.0.012120-0","article-title":"N-linked glycans on dengue viruses grown in mammalian and insect cells","volume":"90","author":"Hacker","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0405","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2004-11-4267","article-title":"HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation","volume":"105","author":"Neil","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2015.02.002_bib0410","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1128\/JVI.01180-10","article-title":"Characterization of the envelope glycoproteins associated with infectious hepatitis C virus","volume":"84","author":"Vieyres","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.02.002_bib0420","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1128\/JVI.01662-14","article-title":"Uukuniemi phlebovirus assembly and secretion leave a functional imprint on the virion glycome","volume":"88","author":"Crispin","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0430","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1074\/jbc.M706292200","article-title":"A novel mechanism for LSECtin binding to ebola virus surface glycoprotein through truncated glycans","volume":"283","author":"Powlesland","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.02.002_bib0435","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/rcm.4410","article-title":"Identification of N-glycans from ebola virus glycoproteins by matrix-assisted laser desorption\/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry","volume":"24","author":"Ritchie","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.coviro.2015.02.002_bib0440","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1128\/JVI.01344-08","article-title":"Crystal structure and carbohydrate analysis of nipah virus attachment glycoprotein: a template for antiviral and vaccine design","volume":"82","author":"Bowden","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0445","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1128\/JVI.00317-10","article-title":"Dimeric architecture of the hendra virus attachment glycoprotein: evidence for a conserved mode of assembly","volume":"84","author":"Bowden","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0450","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1128\/JVI.00761-09","article-title":"Unusual molecular architecture of the machupo virus attachment glycoprotein","volume":"83","author":"Bowden","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/58.1.19","article-title":"Evolutionary and immunological implications of contemporary HIV-1 variation","volume":"58","author":"Korber","year":"2001","journal-title":"Br Med Bull"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0460","doi-asserted-by":"crossref","first-page":"e23521","DOI":"10.1371\/journal.pone.0023521","article-title":"The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade","volume":"6","author":"Bonomelli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0465","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"Doores","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.02.002_bib0470","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells","volume":"265","author":"Leonard","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.02.002_bib0475","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1021\/bi000432m","article-title":"Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells","volume":"39","author":"Zhu","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.coviro.2015.02.002_bib0480","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/pr300870t","article-title":"Characterization of host-cell line specific glycosylation profiles of early transmitted\/founder HIV-1 gp120 envelope proteins","volume":"12","author":"Go","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.coviro.2015.02.002_bib0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2010.03.021","article-title":"Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, griffithsin, cyanovirin-N and scytovirin","volume":"402","author":"Alexandre","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0490","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Julien","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0495","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1245627","article-title":"Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Lyumkis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0500","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0505","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2010.02.019","article-title":"Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function","volume":"401","author":"Eggink","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.02.002_bib0510","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"Kwong","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0515","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0520","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0525","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0530","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0535","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0540","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0545","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"Moldt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0550","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"Shingai","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2015.02.002_bib0555","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A blueprint for HIV vaccine discovery","volume":"12","author":"Burton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.02.002_bib0560","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.02.002_bib0565","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1\u21922 mannose residues on the outer face of gp120","volume":"76","author":"Scanlan","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0570","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"Bonsignori","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0575","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2015.02.002_bib0580","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41\u2013gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0585","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"Calarese","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0590","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1128\/JVI.01229-14","article-title":"Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy","volume":"88","author":"Murin","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0595","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"Kong","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0600","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"Pejchal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0605","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1073\/pnas.1217537110","article-title":"Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9","volume":"110","author":"Julien","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.02.002_bib0610","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nsmb.2600","article-title":"Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16","volume":"20","author":"Pancera","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0615","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"McLellan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0620","doi-asserted-by":"crossref","first-page":"16644","DOI":"10.1074\/jbc.M113.528224","article-title":"Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan","volume":"289","author":"Haji-Ghassemi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.02.002_bib0625","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1073\/pnas.0915176107","article-title":"Antibody recognition of a unique tumor-specific glycopeptide antigen","volume":"107","author":"Brooks","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.02.002_bib0630","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nsmb.2627","article-title":"Antibodies expose multiple weaknesses in the glycan shield of HIV","volume":"20","author":"Crispin","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0635","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/glycob\/cwq020","article-title":"Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans","volume":"20","author":"Dunlop","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.coviro.2015.02.002_bib0640","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1097\/QAD.0b013e328314b5df","article-title":"Antigenic mimicry of the HIV envelope by AIDS-associated pathogens","volume":"22","author":"Dunlop","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2015.02.002_bib0645","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/JVI.01349-10","article-title":"Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans","volume":"85","author":"Agrawal-Gamse","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0650","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cbpa.2013.10.001","article-title":"Synthetic carbohydrate antigens for HIV vaccine design","volume":"17","author":"Wang","year":"2013","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0655","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1128\/JVI.01110-10","article-title":"Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged","volume":"84","author":"Doores","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0660","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nchembio.1288","article-title":"Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies","volume":"9","author":"Amin","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0665","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"Garces","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.02.002_bib0670","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.02905-14","article-title":"Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope","volume":"89","author":"Doores","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0675","doi-asserted-by":"crossref","first-page":"e1003754","DOI":"10.1371\/journal.ppat.1003754","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.02.002_bib0680","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chom.2014.08.006","article-title":"Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies","volume":"16","author":"Kepler","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0685","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","volume":"509","author":"Doria-Rose","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.02.002_bib0690","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/nm.2985","article-title":"Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape","volume":"18","author":"Moore","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2015.02.002_bib0695","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/JVI.00420-14","article-title":"Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses","volume":"88","author":"Iba","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0700","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.02.002_bib0705","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(02)00183-3","article-title":"Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of ebola virus","volume":"58","author":"Barrientos","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.02.002_sbref0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.09.012","article-title":"The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against zaire ebola virus","volume":"112C","author":"Garrison","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.02.002_bib0715","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1021\/mp400399b","article-title":"Inhibition of hepatitis C virus by the cyanobacterial protein microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA","volume":"10","author":"Kachko","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.coviro.2015.02.002_bib0720","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2009.01.043","article-title":"Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection","volume":"387","author":"Alen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.02.002_bib0725","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cbpa.2013.12.017","article-title":"Using glycan microarrays to understand immunity","volume":"18","author":"Arthur","year":"2014","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.coviro.2015.02.002_bib0730","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J Immunol Methods"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T14:58:35Z","timestamp":1651417115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625715000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":73,"alternative-id":["S1879625715000267"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.02.002","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}